Stephen D. Griffin Insider Profile
4 Followers
Stephen D. Griffin, President & CEO, Director at Anika Therapeutics, holds 45.97K shares in Anika Therapeutics (Ticker: ANIK), holds 28.76K shares in VSE (Ticker: VSEC).
Stephen D. Griffin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stephen D. Griffin holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Stephen D. Griffin
Stephen D. Griffin's Trading History
Anika Therapeutics
Jun 05, 2026
President & CEO, Director
Uninformative Buy
130.71K
$967.27K
VSE
Apr 02, 2024
SVP & CFO
Uninformative Buy
215.52K
$5.95M
List of latest transactions for each holding click on a transaction to see Stephen D. Griffin's performance on stock
You May Also Like
Stephen D. Griffin insider profile FAQ
What is the percentage of profitable transactions made by Stephen D. Griffin?
The percentage of profitable transactions made by Stephen D. Griffin is ―.
What is the average return per transaction made by Stephen D. Griffin?
The average return per transaction made by Stephen D. Griffin is ―.
What stocks does Stephen D. Griffin hold?
Stephen D. Griffin holds: ANIK, VSEC stocks.
What was Stephen D. Griffin’s latest transaction?
Stephen D. Griffin latest transaction was an Uninformative Buy of $130.71K.
What was Stephen D. Griffin's most profitable transaction?
Stephen D. Griffin’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Stephen D. Griffin's role in Anika Therapeutics?
Stephen D. Griffin's role in Anika Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.